AbbVie upscales Voyager alliance with new target, more cashAbbVie has extended its collaboration with gene therapy specialist Voyager Therapeutics, adding a new programme in Parkinson’s disease Share XAbbVie upscales Voyager alliance with new target, more cashhttps://pharmaphorum.com/news/abbvie-upscales-voyager-alliance-with-new-target-more-cash/
Ex-Roche, Novartis, AstraZeneca leaders appointed to biotech rolesThree more big pharma R&D names have made the jump to biotech as Voyager Therapeutics, ImmunSYS and Immunocore Share XEx-Roche, Novartis, AstraZeneca leaders appointed to biotech roleshttps://pharmaphorum.com/news/ex-roche-novartis-astrazeneca-leaders-appointed-to-biotech-roles/
